Efficacy and acceptability of psilocybin for primary or secondary depression: a systematic review and meta-analysis of randomized controlled trials https://t.co/4BS5x8dwdu
Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2024 – Mar 2025Where it's discussed
-
X / Twitter14 posts
-
YouTube3 videos
AI synopsis
What people are saying
The collective discussions reflect optimism about psilocybin's antidepressant effects, with phrases like 'promising' and mentions of 'large positive effects,' indicating their recognition of research significance. Words such as 'acceptability' and 'efficacy' along with references to recent meta-analyses contribute to the perception of impactful scientific findings, while some comments show curiosity about safety and future studies.
Most discussions acknowledge the positive findings of the meta-analysis, with some explicitly supporting the therapeutic potential of psilocybin for depression.
The discussions demonstrate high interest, highlighting the significance of recent research, with posts referencing new studies and their implications.
Participants show moderate engagement, with some summarizing key points and considering clinical relevance, though few delve deeply into methodological details.
The discussions hint at the potential influence of these findings for mental health treatment, though they remain cautious about fully endorsing widespread use at this stage.
Abstract in brief
- Psilocybin has been shown to have significant antidepressant effects in recent studies, especially in treating both primary and depression related to severe illnesses, with larger doses producing better results.
- The meta-analysis of 8 studies with 524 adults found a large positive effect of psilocybin on depression, and its side effects are usually temporary, although serious adverse events can happen.
- Overall, psilocybin appears to be a promising short-term and long-term treatment for depression, but more research is needed to fully understand its therapeutic potential and safety profile.
Top posts
Most liked on X and BlueskyNew Research: Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials: Introduction Psilocybin is a classic psychedelics, which has been shown to… https://t.co/Shpm1UoK9p #Psychiatry
Efficacy and acceptability of psilocybin for primary or secondary depression https://t.co/Zne83IhBEC
Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials https://t.co/qzALojxu0E https://t.co/CFjGNU7K5c
Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials https://t.co/PmvO8Dpob9 https://t.co/pqNMigrfrI
Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials https://t.co/N3eRxmm33e
All mentions
EVERYTHING You NEED To Know About Psilocybin Mushrooms!
Exploring the Therapeutic Potential of Psilocybin
In this episode, Dr. Jessica Steier and Dr. Sarah Scheinman explore psilocybin, commonly known as magic mushrooms. They discuss its historical significance, neurobiological mechanisms, and investigate its potential…
The Science of Psilocybin: Therapeutic Insights and Research Overview
In this episode, Dr. Jessica Steier and Dr. Sarah Scheinman explore the world of psilocybin, examining its historical significance, neurobiological mechanisms, and therapeutic potential for mental health conditions…
Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials https://t.co/bxkTqJsr1U
RT @agingdoc1: Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of rando…
Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials https://t.co/N3eRxmm33e
Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials https://t.co/PmvO8Dpob9 https://t.co/pqNMigrfrI
Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials https://t.co/qzALojxu0E https://t.co/CFjGNU7K5c
RT @BellevueDoc: Efficacy and acceptability of psilocybin for primary or secondary depression https://t.co/Zne83IhBEC
RT @BellevueDoc: Efficacy and acceptability of psilocybin for primary or secondary depression https://t.co/Zne83IhBEC
Efficacy and acceptability of psilocybin for primary or secondary depression https://t.co/Zne83IhBEC
RT @BellevueDoc: Efficacy and acceptability of psilocybin for primary or secondary depression: a systematic review and meta-analysis of ran…
RT @BellevueDoc: Efficacy and acceptability of psilocybin for primary or secondary depression: a systematic review and meta-analysis of ran…
RT @BellevueDoc: Efficacy and acceptability of psilocybin for primary or secondary depression: a systematic review and meta-analysis of ran…
RT @BellevueDoc: Efficacy and acceptability of psilocybin for primary or secondary depression: a systematic review and meta-analysis of ran…
Efficacy and acceptability of psilocybin for primary or secondary depression: a systematic review and meta-analysis of randomized controlled trials https://t.co/4BS5x8dwdu
New Research: Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials: Introduction Psilocybin is a classic psychedelics, which has been shown to… https://t.co/Shpm1UoK9p #Psychiatry
JM
FP
T
A
TR
MS
SL
E
L
BW